NCT00443105Unknown2 期
Topical Tacrolimus 0.03% Ointment for Intractable Allergic Conjunctivitis: An Open Label Pilot Study
适应症
相关药物
试验速览
- 阶段
- 2 期
- 试验地点
- 2
研究概览
简要总结
The purpose of this study is to determine the efficacy, tolerance and safety of tacrolimus 0.03% ointment in the treatment of intractable allergic conjunctivitis.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 5 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subjects included if they were > 5 years old and suffered from intractable allergic conjunctivitis
排除标准
- •pregnancy or breastfeeding,history of herpetic eye disease,transplant patients concomitant administration of drugs inhibiting cytochrome CYP3A4, hypersensitivity to macrolides
研究者
研究点 (2)
Loading locations...
相似试验
Unknown
1 期
Effectivness of Topical Tacrolimus Monotherapy in Patients With VitiligoVitiligoTacrolimusNCT03358082Sohag University100
已完成
1 期
Safety and Efficacy of Topical Tacrolimus 0.05% in the Treatment of Ocular Graft-Versus-Host DiseaseOcular GVHDNCT01977781Massachusetts Eye and Ear Infirmary40
已完成
4 期
An Efficacy and Safety Study of Tacrolimus Ointment in Adult Participants With Atopic DermatitisDermatitis, AtopicNCT01828879Janssen-Cilag Ltd.,Thailand74
已完成
4 期
An Efficacy and Safety Study of Tacrolimus Ointment in Pediatric Participants With Atopic DermatitisDermatitis, AtopicNCT01782729Janssen-Cilag Ltd.,Thailand30
已完成
2 期
Tacrolimus Ointment Long Term Safety in Young Children With Atopic DermatitisDermatitis, AtopicNCT00560326Astellas Pharma Inc50